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ABSTRACT: Bacteria exhibit a myriad of different morphologies, through the
synthesis and modification of their essential peptidoglycan (PG) cell wall. Our
discovery of a fluorescent D-amino acid (FDAA)-based PG labeling approach
provided a powerful method for observing how these morphological changes
occur. Given that PG is unique to bacterial cells and a common target for
antibiotics, understanding the precise mechanism(s) for incorporation of
(F)DAA-based probes is a crucial determinant in understanding the role of
PG synthesis in bacterial cell biology and could provide a valuable tool in the
development of new antimicrobials to treat drug-resistant antibacterial
infections. Here, we systematically investigate the mechanisms of FDAA probe
incorporation into PG using two model organisms Escherichia coli (Gram-
negative) and Bacillus subtilis (Gram-positive). Our in vitro and in vivo data
unequivocally demonstrate that these bacteria incorporate FDAAs using two extracytoplasmic pathways: through activity of
their D,D-transpeptidases, and, if present, by their L,D-transpeptidases and not via cytoplasmic incorporation into a D-Ala-D-
Ala dipeptide precursor. Our data also revealed the unprecedented finding that the DAA-drug, D-cycloserine, can be
incorporated into peptide stems by each of these transpeptidases, in addition to its known inhibitory activity against D-alanine
racemase and D-Ala-D-Ala ligase. These mechanistic findings enabled development of a new, FDAA-based, in vitro labeling
approach that reports on subcellular distribution of muropeptides, an especially important attribute to enable the study of
bacteria with poorly defined growth modes. An improved understanding of the incorporation mechanisms utilized by DAA-
based probes is essential when interpreting results from high resolution experiments and highlights the antimicrobial potential of
synthetic DAAs.
■ INTRODUCTION
Of the known bacterial species, nearly all possess a
peptidoglycan (PG) cell wall that surrounds the cell. PG is
an essential cellular component that maintains the size and
shape of the bacterial cell and helps protect the cell from its
environment. Given its essential roles in cell growth and
division, its relative accessibility when compared to potential
cytoplasmic targets, and that it is unique to bacterial cells,
some of the most successful antibiotics target PG biosyn-
thesis.1
The PG cell wall is a macromolecule consisting of glycan
strands cross-linked by short D-amino acid (DAA)-containing
peptides. The PG biosynthetic pathway is promiscuous with
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respect to the assembly and/or utilization of the D-Ala-D-Ala
(DADA) subunit at the terminus of the pentapeptide
stem,2,3 and these steps are targets of many clinically important
anti-PG drugs such as D-cycloserine (DCS), the β-lactams, and
vancomycin4 (Figure 1a). Interestingly, DCS, a second-line
drug currently used to treat multidrug-resistant strains of M.
tuberculosis,4 and many β-lactams, are DAAs, while their mirror
image counterparts (i.e., the L-enantiomers) show remarkably
diminished antibacterial activities.5−7
The DA−DA subunit is assembled in the cytoplasm by D-
Ala-D-Ala ligase (Ddl) and is appended to UDP-MurNAc-
tripeptide by MurF to provide UDP-MurNAc pentapeptide
(Figure 1a). After additional downstream processing into a
C55-lipid-linked disaccharide pentapeptide (lipid II), this
monomeric PG subunit is translocated across the cytoplasmic
membrane and incorporated into elongating glycan strands in
the periplasm. Subsequently, the DA−DA subunit of the stem
peptide is a substrate for cross-linking reactions that are
essential for providing the PG cell wall with the requisite load-
bearing properties against the cell’s turgor pressure. These
cross-links are installed by two distinct pathways: (1) the
essential and ubiquitous D,D-transpeptidases (D,D-TPases or
penicillin binding proteins, PBPs) that catalyze installation of
4−3 cross-links, or (2) the normally dispensable and more
infrequent, L,D-transpeptidases (L,D-TPases) that catalyze
installation of 3−3 cross-links (Figure 1a).8
Elucidating the molecular mechanisms regulating PG
biosynthesis will provide valuable insights that can be applied
to combat the alarming increase of multidrug resistance.9
Toward this goal, we and others have recently developed new
classes of synthetic D-amino acid (DAA) based probes to
visualize PG assembly and dynamics in virtually all PG-
containing bacterial species.10−18 These probes, fluorescent D-
amino acids (FDAAs), clickable DAAs, and D-amino acid
dipeptides (DAADs), have advanced our fundamental knowl-
edge of bacterial growth and division in diverse bacte-
ria.10,14−53 In order to make maximal use of the data obtained
from labeling experiments utilizing these probes, a detailed
understanding of probe incorporation mechanisms is required.
Here we have systematically characterized the incorporation
mechanisms of common DAA-based probes in two model
organisms: Gram-positive B. subtilis and Gram-negative E. coli.
We leveraged chemical genetics, genetics, microscopy, and in
vitro approaches in combination with labeling experiments that
utilized: EDA, a small clickable DAA; HADA, an FDAA; along
with EDA−DA and DA−EDA, two clickable small DAADs
(Figure 1b). Our data suggest that DAADs are incorporated
using the cytoplasmic (lipid II) pathway, while single DAA-
based probes (e.g., EDA, HADA) are incorporated outside the
cytoplasm by the D,D-TPases, and, if present, the L,D-TPases.
Our chemical genetics experiments revealed a previously
unknown mode of action for DCS; specifically, that it is a
substrate for both D,D-TPases and L,D-TPases and that it is
readily incorporated into pentapeptide and tetrapeptide stems,
respectively (Figure 1b), perhaps providing an important
insight for further investigation of novel D-amino acid-based
antibacterial agents. Finally, our improved mechanistic under-
standing helped us design a new, FDAA-based labeling
approach that reports on subcellular distribution of muropep-
tides in bacterial cells.
■ RESULTS
Chemical Genetics Approach Reveals Transpepti-
dase-Mediated Incorporation of DAAs in Bacillus
subtilis. In order to probe the mechanism of FDAA
incorporation in vivo, we first attempted a chemical genetics
approach. Since bacterial species usually have multiple L,D-
TPases and/or commonly essential D,D-TPases, deleting them
all is not feasible. We first focused on vegetative B. subtilis cells
that reportedly lacked 3,3-cross-links typical of L,D-TPase
activity.54 This reduced the potential modes of FDAA
installation to incorporation by the D,D-TPases or to
cytoplasmic incorporation via the lipid II pathway. In order
to verify the lack of L,D-TPase mediated incorporation, we
prelabeled vegetative B. subtilis cells with HADA. This was
followed by ethanol-fixing and permeabilization of the cells
followed by treatment with an E. coli D,D-carboxypeptidase/
endopeptidase (PBP4Ec, the product of the dacB gene), in vitro.
While PBP4Ec did not remove HADA from tetrapeptides in E.
Figure 1. PG biosynthetic pathways are promiscuous and accept D-amino acid (DAA) based probes. (a) Simplified cartoon representation of the
PG synthesis and modification pathways relevant to this work, along with representative PG synthesis inhibitors. (b) Representative DAA-based
probes utilized in the experiments described in this manuscript.
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coli cells (Figure SI1a), it completely removed the signal from
vegetative ethanol-fixed pentapeptide-rich B. subtilis ΔdacA
cells prelabeled with HADA (Figure SI1b). These results are in
agreement with previous observations that vegetative B. subtilis
cells incorporate HADA exclusively into their pentapeptides.15
In the absence of L,D-TPase activity, chemical inhibition of
extracellular D,D-TPases or inhibition of cytoplasmic D-Ala-D-
Ala synthesis and incorporation could provide valuable
information on the route of FDAA incorporation. We first
confirmed that cells remained viable after such brief drug
exposures (Figure SI1c), consistent with a recent report.55 Our
initial experiments screening different FDAAs and drugs
showed that both β-lactams and D-cycloserine (DCS) had
the potential to significantly inhibit the incorporation of
FDAAs in live B. subtilis in a drug- and FDAA-dependent
manner (Figures 2a and SI1c). For example, the inhibition by
DCS was particularly pronounced and comparable to penicillin
G, a β-lactam, when the FDAA was TDL, a large red FDAA
linked to D-lysine, (∼65−80% inhibition, Figure 2a). A similar
effect was observed in E. coli wild-type cells. While D-
cycloserine and ampicillin both inhibited HADA incorporation
(by ∼30%), meropenem inhibited virtually all HADA
incorporation (Figure SI1d).
Given the significant inhibition observed for both DCS and
β-lactamsand the well-characterized inhibitory activity of the
β-lactams toward the bacterial transpeptidaseswe postulated
that DCS, a cyclized D-serine analogue with a free amino
group (Figure 1b), might behave as a competitive inhibitor of
periplasmic L,D- and/or D,D-TPases. In support of this
hypothesis, both LdtAVc, a representative L,D-TPase from
Vibrio cholerae,56 and PBP4Sa, a soluble version of recombinant
PBP4 from Staphylococcus aureus,17 incorporated DCS into
Figure 2. B. subtilis cells do not incorporate (F)DAAs cytoplasmically, but through reactions mediated by D,D-TPases, which can be inhibited by
D-cycloserine. (a) A brief pretreatment of live B. subtilis cells with vancomycin, penicillin G (Pen G), and D-cycloserine (DCS), significantly
inhibited FDAA incorporation. No inhibition of FDAA incorporation was obsereved with fosfomycin. (b) LdtAVc incorporated DCS into M4,
comparable to other DAAs, e.g., D-Met, in vitro. (c) PBP4Sa incorporated DCS into a synthetic Nα, Nε-Diacetyl-L-Lys-D-Ala-D-Ala tripeptide (3P),
in vitro. (d) Live B. subtilis wild-type and B. subtilis Δddl cells, grown in S750 minimal media supplemented with DA−DA, incorporated HADA
comparably; HADA incorporation was significantly inhibited by ampicillin pretreatment. (e) DA−EDA was a poor substrate for MurFBs in vitro,
but EDA−DA performed similarly well to the endogenous substrate, DA−DA. Column bar graphs represent mean relative signal ± SD quantified
from at least N > 100 cells. Error bars are SEM.
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appropriate soluble substrate analogues in vitro:13 LdtAVc
incorporated DCS into tetrapeptides comparably to D-
methionine, a DAA that is naturally produced by Vibrio
cholerae cells2 (Figure 2b); the product of each reaction was
confirmed by MS (Figure SI2a). PBP4Sa incorporated DCS
into a synthetic Nα, Nε-diacetyl-L-Lys-D-Ala-D-Ala tripeptide
(3P) albeit to a lower extent when compared to identical
experiments utilizing D-methionine (Figure 2c). Moreover,
excess DCS directly competed with incorporation of FDAAs
into ethanol-fixed cells by LdtAVc in a FDAA-specific manner
(Figure SI2b). These data suggest that, in addition to its
known cytoplasmic targets (alanine racemase and D-Ala-D-Ala
ligase),57 DCS, a clinically important antibiotic, has the
previously uncharacterized potential to competitively inhibit
L,D- and D,D-TPases, and therefore its utilization would not
yield clear results probing (F)DAA incorporation mechanisms.
Vegetative B. subtilis Cells Incorporate FDAAs with
D,D-TPases and Not Cytoplasmically. Given these
difficulties, we turned to a conventional genetics approach
for deletion of nonessential (or conditionally essential)
Figure 3. E. coli cells incorporate (F)DAAs through reactions mediated by L,D- and D,D-TPases, and not cytoplasmically. (a) HADA incorporation
in E. coli BW25113Δ6LDT cells (Δ6LDT) was ∼10-fold lower than that observed in E. coli wild-type cells. Unlike wild-type cells, which reveal
extensive accumulation of FDAA signal around the entire cell, FDAA labeling in the Δ6LDT strain was predominantly limited to the sites of new
growth. (b) Live E. coli wild-type cells, but not Δ6LDT cells, incorporated FDAAs in a growth-independent manner. (c) Live E. coli Δ6LDTΔdacA
cells accumulated significantly more HADA signal compared to Δ6LDT. (d) Live Δ6LDT and E. coli Δ6LDTΔddlAB cells, grown in M9 minimal
media supplemented with DA−DA, incorporated HADA comparably; HADA incorporation was inhibited by ampicillin pretreatment. (e)
Compared to D-Ala, EDA was a poor substrate for DdlBE. coli in vitro. Micrographs are adjusted for qualitative comparison only. Values in column
bar graphs represent mean relative signal quantified from at least N > 100 cells. Scale bars, 2 μm.
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pathways and interrogation of potential DAA incorporation
mechanisms through comparison of FDAA accumulation
between otherwise isogenic strains. Because vegetative B.
subtilis cells lack L,D-TPase activity (Figure SI1b), knocking
out its ability to form DA−DA would also eliminate its ability
to incorporate DAAs cytoplasmically and leave D,D-trans-
peptidation as the only feasible route for DAA incorporation
(Figure 1a). Deleting the single and essential DA−DA-ligase
gene (ddl) in B. subtilis provided a strain that was auxotrophic
for exogenously provided DA−DA. Under identical growth
conditions, wild-type B. subtilis and B. subtilis Δddl cells
accumulated a HADA signal to a comparable extent, while
ampicillin treatment inhibited >80% of their initial signal
(Figure 2d). This result strongly suggests that FDAAs are not
incorporated cytoplasmically in B. subtilis.
Our in vitro findings with MurF from Bacillus subtilis
(MurFBs), the next cytoplasmic enzyme downstream of Ddl,
support the conclusion that FDAAs are not incorporated
cytoplasmically in B. subtilis. These experiments revealed that
MurFBs accepted EDA−DA, a clickable DAAD that eventually
generates lipid II tagged in the fourth position of the
pentapeptide stem,16 as well as its endogenous substrate,
DA−DA both in terms of its affinity and turnover (Figure 2e).
However, DA−EDA, a DAAD that generates a pentapeptide
tagged in the fifth (i.e., terminal) position, is a significantly
poorer (∼20-fold) substrate than DA−DA. This observation,
along with the enzymatic activity of the endogenous
carboxypeptidases (e.g., PBP5), may explain the differential
DAAD labeling previously observed in live B. subtilis cells;
specifically, EDA−DA labeled the PG of B. subtilis much more
strongly than DA−EDA.16 The in vitro data also suggest that
cytoplasmic DAA incorporation into the terminal position of
the pentapeptide stem (e.g., with DA-EDA)the pentapeptide
terminus is the only site labeled by (F)DAAs in vegetative B.
subtilis cells (Figure SI1b)is particularly disfavored by MurF
in B. subtilis (Figure 2e). Furthermore, excess DA−DA did not
significantly compete with the FDAA label accumulation in live
vegetative B. subtilis cells, but D-alanine and D-tyrosine, a DAA
that is naturally produced by B. subtilis cells,2 (>50-fold
decrease) did (Figure SI2c). Thus, we conclude that (F)DAAs
are not incorporated cytoplasmically in vegetative B. subtilis
cells. By the process of genetic elimination and in combination
with the Supporting Information, our results strongly suggest
that, in vegetative B. subtilis cells, FDAAs are incorporated
predominantly (if not solely) through the activity of the
periplasmic D,D-transpeptidases.
E. coli Cells Incorporate FDAAs by L,D-TPases in a
Growth Independent Manner. In contrast to B. subtilis, E.
coli is rich in L,D-TPase activity.58 We recently reported on a
mutant E. coli strain in which all the predicted L,D-TPases
were de le ted.36 Cel l s f rom this s t ra in , E. co l i
BW255113Δ6LDT (hereafter referred to as Δ6LDT), revealed
a ∼10-fold lower HADA signal compared to wild-type E. coli
(Figure 3a). Among the six single L,D-TPase knockout strains,
ΔldtD cells showed the least HADA incorporation (∼50%,
Figure SI3a). Consistently, double, triple, and quadruple L,D-
TPase mutants showed a significant decrease in label
incorporation compared to wild-type as long as ldtD is one
of the deleted genes (Figure SI3b). These results suggest that
the major mode(s) of FDAA incorporation in actively growing
E. coli is due to the L,D-TPases, primarily LdtD.41
Early labeling experiments revealed that wild-type E. coli
cells begin to accumulate FDAA signal at sites of new growth
(i.e., septum and side walls) eventually plateauing into
uniformly labeled cells over 1−2 generations.15 In contrast,
E. coli Δ6LDT cells accumulate FDAA signal to a lower extent
and preserve the signal persistently at sites of new growth
(Figure 3a). This uniform and peripheral accumulation of
FDAA signal in wild-type E. coli cells suggested a growth-
independent, L,D-Tpase-facilitated DAA incorporation.
Consistently, nutrient starved cells, which are kept in
phosphate buffered saline (PBS) for 1 h at RT, of wild-type
E. coli incorporated HADA strongly and uniformly, whereas E.
coli Δ6LDT cells did not show any significant signal
accumulation above background (Figure 3b). A complementa-
tion assay with nutrient starved E. coli cells suggested that this
growth independent FDAA incorporation in buffer was
predominantly due to overexpression of L,D-TPase genes
known to generate 3−3 cross-links, ldtD and ldtE,58 and less so
due to L,D-TPases that anchor Braun’s lipoprotein (ldtA, ldtB,
or ldtC) or yaf K (Figure SI3c). This property was not specific
to E. coli. Diverse bacteria rich in predicted L,D-TPases, such
as the deltaproteobacterium Bdellovibrio bacteriovorus36 and the
alphaproteobacterium Agrobacterium tumefaciens,27 also in-
corporated HADA in a growth-independent manner (Figure
SI 3d).
Collectively, these results suggested that L,D-TPase
mediated DAA incorporation in E. coli can occur independ-
ently of cell growth.59 On the other hand, the persistent signal
observed in the absence of L,D-TPase activity (Figure 3a)
points to the presence of an additional mode for DAA
incorporation in E. coli.
D,D-TPases Incorporate DAAs into the Pentapeptides
of PG in E. coli Cells. Pentapeptides are rare in E. coli PG.60
We hypothesized that the relatively faint FDAA signal localized
at sites of new growth in cells lacking L,D-TPases represented
probe incorporation into pentapeptides. If so, deleting the gene
for one of the major E. coli D,D-CPases (dacA) in this
background should increase the FDAA labeled pentapeptide
pools in E. coli PG. Indeed, E. coli Δ6LDTΔdacA cells showed
2-fold greater incorporation of HADA signal than E. coli
Δ6LDT (Figure 3c). We observed that HADA accumulation
in E. coli Δ6LDTΔdacA cells could be eliminated by treatment
with a carboxy/endopeptidase (PBP4Ec) in vitro (Figure SI4a).
The labeling trends observed with these mutants and EDA, a
small clickable DAA, were comparable (Figure SI4b). These
results reveal previously underappreciated DAA incorporation
into pentapeptides in E. coli.
This pentapeptide labeling, could be achieved via the
cytoplasmic route (through Ddl/MurF), an exchange reaction
mediated by the D,D-transpeptidases (i.e., the PBPs), or a
combination of the two. Therefore, we deleted ddlA and ddlB
on top of 6 L,D-TPases generating an E. coli Δ6LDTΔddlAB
strain that is auxotrophic for DA−DA. This mutant strain lacks
both L,D-TPase activity and the ability to incorporate DAAs
cytoplasmically. Similar to the aforementioned case in B.
subtilis, E. coli Δ6LDTΔddlAB cells accumulated HADA
(Figure 3d) or EDA (Figure SI4c) signals comparably to
identically treated E. coli Δ6LDT cells. Ampicillin treatment
significantly inhibited HADA accumulation in both strains
(Figure 3d). Moreover, DCS significantly inhibited (F)DAA
signal incorporation even in the absence of Ddl, and in the
presence of excess DA−DA, in both E. coli and B. subtilis
(Figure SI4c-d), providing further support for the notion that
DCS may also function as a DAA-like competitive inhibitor of
D,D-TPases in both organisms. Collectively, these results
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suggest that the D,D-TPases, and not the cytoplasmic enzymes,
are primarily responsible for incorporation of DAAs into
pentapeptides in E. coli and in B. subtilis.
Ddl Disfavors the Cytoplasmic Incorporation of
DAAs. For cytoplasmic incorporation, following cellular
import, a (F)DAA needs to be tolerated by Ddl and
incorporated into a corresponding DAAD. To test our
conclusion that (F)DAAs are not incorporated cytoplasmically,
we assessed the ability of E. coli DdlB (DdlBEc) to ligate D-Ala
to EDA, the small clickable DAA, forming DA−EDA, in vitro.
Under previously published conditions, DdlBEc showed 2-fold
higher affinity for EDA than for D-Ala; however, the apparent
rate of the reaction with EDA was 10-fold slower than the
reaction with D-Ala (Figure 3e). This suggests that
cytoplasmic (F)DAA incorporation may be primarily rejected
by Ddl, especially since the cytoplasmic steps lying down-
stream of Ddl seem to be significantly more tolerant.16 Indeed,
MurF from Pseudomonas aeruginosa (MurFPa, an enzyme that
shows high sequence and kinetic similarity to E. coli MurF61)
incorporated both of the clickable DAADs, EDA−DA and
DA−EDA, with comparable rates and affinities to the native
substrate, DA−DA (Figure 4a). This tolerance of MurF (and
presumably the downstream steps) could explain how small
DAADs could be used as common and versatile metabolic PG
labeling alternatives to FDAAs and why they can rescue DA−
DA deficiencies in E. coli, B. subtilis, and Chlamydiae.16,37
Lastly, we wanted to test if E. coli L,D-TPases play a role in
DAAD incorporation. Cells from E. coli Δ6LDT grown for 1−
2 generations in the presence of EDA−DA incorporated
approximately 20% more DAAD signal compared to wild-type
E. coli cells (Figure 4b). These data provide strong evidence
that L,D-TPases do not play a significant role in DAAD
incorporation.
From our combined results, we conclude that the
incorporation of FDAA and DAAD probes can be used to
distinguish between two distinct biosynthetic pathways. FDAA
probe incorporation reports on the activity of the extrac-
ytoplasmic L,D- and D,D-TPases, whereas DAAD probe
incorporation reports on the cytoplasmic (lipid II) pathway,
i.e., nascent PG synthesis (Figure 4c).
FDAAs Report on L,D- and D,D-TPase Activity and
Muropeptide Distribution in Fixed Cells. Our results and
previous in vitro work with D-amino acids (DAAs) revealed
that both L,D-TPases and D,D-TPases of different bacterial
origins can utilize DAAs as acyl-acceptor substrates in the
presence of appropriate acyl-donors.17,56,62 Consistently,
representative enzymes with known L,D-TPase or D,D-
TPase activities could utilize larger fluorescent DAAs
(FDAAs) as acyl-acceptor substrates in vitro. A representative
Figure 4. FDAAs are incorporated by periplasmic transpeptidases and DAADs cytoplasmically. (a) MurFPa incorporated DAADs as well as the
native substrate (DA−DA), in vitro. (b) Live Δ6LDT cells incorporated a greater EDADA (1 mM for 1 h) signal than E. coli wild-type cells.
Values in column bar graphs represent the mean relative signal quantified from at least N > 150 cells. (c) Cartoon representation depicting that in
E. coli DAAs, including FDAAs and DCS, are substrates for periplasmic L,D-TPases, D,D-TPases, or D,D-CPases and that DAADs are substrates
for cytoplasmic MurF.
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Figure 5. FDAAs are efficiently incorporated into PG precursors. (a) LdtAVc incorporated HADA into the soluble muropeptide disaccharide
tetrapeptide (M4) comparable to other DAAs, e.g., D-Met, in vitro. (b) Different high-molecular-weight D,D-TPases from diverse bacteria
incorporated HADA and NADA during the in vitro synthesis of nascent PG from lipid-II without significantly changing their total D,D-TPase and
DD,D-CPase product distribution. The values are the mean ± SD of three independent experiments.
Figure 6. FDAAs report on the abundance and subcellular distribution of muropeptides in ethanol fixed and permeabilized bacterial cells in vitro.
(a) Ethanol fixed V. cholerae cells are substrates for LdtAVc and FDAAs, e.g., HADA, in vitro. (b) Ethanol fixed S. aureus cells are substrates for
PBP4Sa and FDAAs in vitro. (c−d) Ethanol fixed E. coli cells are substrates for LdtAVc or PBP4Sa and FDAAs in vitro. (c) FDAAs and LdtAVc can
report on PG tetrapeptide abundance of the E. coli Δ6LDT and ΔdacA strains in vitro. (d) FDAAs and PBP4Sa can report on PG pentapeptide
abundance of the E. coli Δ6LDT and ΔdacA strains in vitro. (e) Sequential PBP4Sa (with HADA) and LdtAVc (with BADA) labeling can report on
differential subcellular muropeptide distribution of a strain, e.g., in ethanol fixed A. tumefaciens cells, red arrows. Column bar graphs represent mean
relative signal quantified from at least N > 100 cells. Error bars are SEM. Scale bars, 2 μm.
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L,D-TPase from Vibrio cholerae (LdtAVc) incorporated HADA
into a soluble disaccharide tetrapeptide (Figure 5a) while four
recombinant high molecular weight PBPs (E. coli, PBP1AEc and
PBP1BEc; Haemophilus inf luenzae, PBP1AHi; and B. subtilis,
PBP1Bs) facilitated incorporation of FDAAs during the
synthesis of nascent PG from a lipid II precursor (Figure
5b). The FDAA incorporation activities were comparable to
naturally produced D-methionine2 (Figure 5a) or were at the
expense of their native cross-linking/carboxypeptidase activ-
ities (Figure 5b). This suggested that FDAAs did not
significantly interfere with the native functions of these
enzymes and could serve as proxy reporters for the DAA
incorporation activities of L,D-TPases or for cross-linking/
carboxypeptidase activities of D,D-TPases.
Next, we tested whether these recombinant transpeptidases
would incorporate FDAAs into isolated sacculi in vitro. Early
attempts with isolated V. cholerae sacculi indicated high
background/nonspecific labeling (Figure SI5a). This led us
to utilize ethanol-fixed and permeabilized intact cells as
transpeptidase substrates, a simple substrate preparation
approach that we have previously employed.16 Treatment of
bacterial cells with ice-cold ethanol inactivates virtually all
cellular activity and permeabilizes membranes for downstream
applications while keeping the cells intact and well separated
for microscopy experiments.16 Indeed, recombinant
LdtAV. cholerae incorporated HADA into ethanol-fixed V. cholerae
cells in vitro (Figure 6a). Label incorporation was specific for
PG (Figure SI5b); parallel experiments with the L-isomer,
HALA, resulted in a 5-fold decrease in fluorescence
incorporation (Figure SI5c). We similarly observed a minor,
and V. cholerae-specific, HALA incorporation in live V. cholerae
cells, but not live E. coli cells, albeit approximately 20-fold less
efficiently than HADA (Figure SI 5d). LdtAVc incorporated
HADA into ethanol-fixed cells from a variety of Gram-negative
species (Figure SI6a). Similarly, a soluble version of
recombinant PBP4 from S. aureus (PBP4Sa)
17 incorporated
HADA into ethanol-fixed Staphylococcus aureus cells (Figure
6b) and ethanol-fixed E. coli cells (Figure SI6b). Recombinant
PBP4Sa also incorporated HALA into fixed E. coli cells,
although it was incorporated approximately 20-fold less
efficiently than HADA (Figure SI6b).
The PG of E. coli is rich in tetrapeptides,58 but the
abundance of pentapeptides increases in strains lacking D,D-
carboxypeptidases60 (e.g., PBP5 encoded by dacA). Consis-
tently, LdtAVc incorporated HADA into ethanol-fixed E. coli
ΔdacA cells comparably to wild-type cells (Figure 6c),
suggesting that the carboxypeptidase activity of DacA may
not significantly impact overall tetrapeptide abundance.
However, a 7-fold increase in HADA incorporation was
observed using ethanol-fixed cells from an E. coli strain that
lacked all of the six known or predicted genes encoding for
L,D-TPases, Δ6LDT (Figure 6c). The enhanced HADA
incorporation in the Δ6LDT strain relative to the wild-type
strain suggests that LdtAVc, combined with the FDAAs, can
report on the relative abundance of tetrapeptides in PG.
On the other hand, PBP4Sa incorporated HADA into fixed
cells from an E. coli strain that lacked a major D,D-CPase,
BW25133ΔdacA, significantly more than the wild-type,
strongly suggesting that pentapeptides are the preferred
substrate for PBP4Sa-mediated HADA incorporation (Figure
6d). Sequential enzymatic labeling of ethanol-fixed cells with
differently colored FDAAs was possible. Treatment of ethanol-
fixed Δ6LDTΔdacA cells with HADA and PBP4Sa, followed by
BADA, a green, BODIPY-FL containing FDAA that is
spectrally distinguishable from HADA, and LdtAVc resulted
in superimposable labeling patterns (Figure SI6c). The same
experimental approach with polarly growing Agrobacterium
tumefaciens cells showed complementary labeling patterns
particularly in young cells; a HADA signal (reporting on
pentapeptides) appeared enriched at the very tip of the
growing pole, followed by a band of BADA signal (reporting
on tetrapeptides, Figure 6e). These results show that L,D- and
D,D-TPases can incorporate FDAAs into ethanol fixed and
permeabilized cells from diverse species in vitro while reporting
on subcellular tetrapeptide/pentapeptide distribution of a
strain. Moreover, these in vitro results support the direct role
of these periplasmic L,D- and D,D-TPases in incorporating
(F)DAAs in different bacteria.
■ DISCUSSION
Bacteria have the evolutionarily preserved ability to produce
DAAs, and their PG biosynthetic pathways are uniquely
promiscuous for utilization of DAAs that provide them with a
survival advantage in the wild.36,63 The design of multiple
classes of DAA-based PG labeling probes that take advantage
of this promiscuity are now widely used.10,14−18,29 While
dissecting the routes for incorporation (and for turnover) of
these PG probes has been challenging, without this knowledge,
the interpretation of the data generated with these probes in a
given species is limited. Here, we provide a roadmap to explore
the mechanisms by which DAA-based probes are incorporated
into the PG by combining genetics, chemical genetics, and in
vitro approaches for two model organisms, E. coli and B.
subtilis. We provide strong evidence that (F)DAAs, including
the DAA drug DCS, are incorporated by extracytoplasmic
(Gram-positive) or periplasmic (Gram-negative) L,D-TPases
and D,D-TPases in contrast to DAADs, which are cytoplasmi-
cally incorporated (Figure 4c).
Prior to our discovery of the FDAAs, previous work with
DAAs2,17 ,29,56 ,62 (e.g., D-methionine) and various
DAADs,3,16,37,49,64 showed that incorporation of any DAA is
tolerated by these D-Ala assembly/utilization steps that are
common in PG containing bacteria. Previous work strongly
suggested DAA probe incorporation was mediated by the
bacterial transpeptidases; however, definitive experiments to
rule out cytoplasmic incorporation had yet to be reported. The
ability to distinguish these pathways has important ramifica-
tions with respect to interpretation of results from FDAA
labeling experiments. For example, cytoplasmic incorporation
of a DAA probe would report on nascent PG synthesis; the
probe would be incorporated into the lipid II intermediate that
would subsequently be detected upon polymerization into
glycan strands. Alternatively, periplasmic incorporation would
report on the localized activity of transpeptidases on the
bacterial cell surface (Figure 1a). Therefore, any cytoplasmic/
periplasmic cross-reactivity of a probe would significantly
complicate either of these interpretations. The mechanistic
picture is further complicated in experiments that are carried
out in the presence of D-cycloserine (DCS). Since DCS is a
well-established inhibitor of alanine racemase and D-Ala-D-Ala
ligase (Ddl), enzymes that are critical for the cytoplasmic
assembly of D-Ala-D-Ala, it is logical to conclude that
diminished DAA probe incorporation in the presence of
DCS is indicative of a cytoplasmic pathway for probe
incorporation. However, our data have revealed that DCS
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has a previously unknown mode of action that also directly
impacts TPase-mediated probe incorporation.
The mechanism question is convoluted partly because of the
essentiality and/or redundancy of enzymes for a particular
route of (F)DAA incorporation. For example, E. coli has 2
Ddls, 6 predicted L,D-TPases, and 12 D,D-TPases/CPases
(i.e., penicillin-binding proteins, PBPs). Understandably, this
creates an opportunity to utilize a chemical genetics approach
where all enzymes in a pathway are inhibited simultaneously,
as we and others have done previously.23,24,35,37,55,56 However,
here we show that implementation of a chemical genetics
approach, based on inhibition of probe incorporation by anti-
PG antibiotics, was insufficient for multiple reasons. Even
when the toxicity of these agents is controlled for, it is difficult
to conclusively rule out indirect effects. For example,
vancomycin inhibits FDAA incorporation in B. subtilis.
However, this effect could arise directly, through inhibition
of D,D-TPase-dependent FDAA incorporation, or indirectly,
through inhibition of nascent PG synthesis that results in
depletion of the substrate utilized in D,D-TPase-mediated
FDAA incorporation. Interpretation of probe incorporation
data obtained with antibiotics was further complicated by
cross-reactivities of drugs like meropenem that inhibit FDAA
incorporation by both the L,D-TPases and the D,D-TPases or,
as demonstrated here, by DCS that inhibits each of the three
possible routes for probe incorporation.
Since DCS is a well-established inhibitor of alanine racemase
and D-Ala-D-Ala ligase (Ddl), enzymes that are critical for the
cytoplasmic assembly of D-Ala-D-Ala, it was initially thought
that diminished DAA probe incorporation in the presence of
DCS was indicative of a cytoplasmic pathway for probe
incorporation. However, our data have revealed that DCS can
directly compete with transpeptidase-mediated (F)DAA
incorporation. This unexpected behavior is likely because
DCS is also a DAA and may point to a heretofore unidentified
mode of action of DCS on TPase-mediated reactions. Indeed,
a D,D-CPase mutation has been shown to confer resistance to
DCS in Mycobacterium.65 Although this multiple target
reactivity makes DCS a problematic reagent for investigation
of FDAA incorporation mechanisms, such reactivity is highly
desirable property for development of a potent drug.
The (F)DAA incorporation activities are driven by the
exchange of the terminal D-Ala residues in tetrapeptides and
pentapeptides catalyzed by L,D- and D,D-TPases (Figure 1a),
respectively. We show that this differential activity can be
utilized to probe the subcellular distribution of tetrapeptides
and pentapeptides by the sequential incubation of recombinant
L,D- and D,D-TPases and differently colored FDAAs with
ethanol-fixed bacterial cells, in vitro. This sample preparation
approach takes less than an hour while keeping the cells intact.
Since the PG that is being labeled by this approach is made
naturally by the strain of interest (i.e., it is label-free), this
method also offers access to a native-like substrate scaffold rich
in information regarding muropeptide spatial distribution. The
visualization of FDAA labeling then decodes this distribution,
the composition of which may vary with cells from different
mutant strains. This method will be particularly useful for
investigating the roles of relative distribution of PG
tetrapeptides and pentapeptides in bacteria with poorly
understood growth modes (e.g., polar growth).20 Indeed, the
dual color labeling in ethanol-fixed Agrobacterium tumefaciens
(Figure 6e) suggests that the polar growth of this bacterium
might necessitate pentapeptide incorporation at the very tip of
the growing cell.
Previous muropeptide analyses suggested that E. coli
incorporate (F)DAAs predominantly into tetrapeptides.15
This label incorporation into tetrapeptides is L,D-TPase
dependent; E. coli cells that lack all six L,D-TPases accumulate
an order of magnitude less (F)DAA signal compared to the
parent. Surprisingly, we observed that evolutionarily diverse
and L,D-TPase-rich Gram negative-bacteria including A.
tumefaciens (14 homologues), E. coli (six homologues), or B.
bacteriovorus (19 homologues36) incorporate FDAAs under
nutrient-starved conditions in a growth-independent manner. In
E. coli, wild-type cells strongly incorporated FDAAs into PG
under nutrient-starved conditions, but an isogenic L,D-TPase-
null strain did not. This explains the loss of observable growth
patterns during prolonged FDAA pulses in E. coli.15 Therefore,
we caution that such growth-independent (F)DAA incorpo-
ration by L,D-TPases (or D,D-TPases39) can obscure the
growth-specific FDAA labeling, especially in extended labeling
experiments.
The signal in the L,D-TPase deficient strains represents
exclusive pentapeptide labeling and a steady-state between
(F)DAA incorporation and its removal by D,D-CPases (e.g.;
PBP4Ec). This pentapeptide labeling could occur either
cytoplasmically, via the combined activities of Ddl and
MurF, or through the activity of the D,D-TPases. Since
deletion (or inhibition) of every available D,D-TPase in a given
bacterial species, without killing the cell, is virtually impossible,
we elucidated their role(s) in incorporating FDAAs into PG of
live E. coli and B. subtilis cells through the process of
elimination. Ddl knockout strains in B. subtilis and E. coli that
also lacked L,D-TPase activity showed (F)DAA labeling
comparable to the parent strains with native Ddl activity.
The observed labeling, in the absence of Ddl and L,D-TPase
activity, provides compelling evidence that D,D-TPases
incorporate (F)DAAs into pentapeptides in the PG of these
two species in vivo. Consistently, β-lactams dramatically reduce
in vivo (F)DAA incorporation into pentapeptides in these
species. Our in vitro data also suggest that bacteria may have an
intrinsic ability to limit utilization of DAAs other than D-Ala
by Ddl and MurF. For example, DdlBEc has a ∼10-fold lower
specific activity toward EDA relative to D-Ala, suggesting that
the cytoplasmic incorporation route may be limited at this
point even if (F)DAAs are taken up by the cell. Similarly,
MurFBs rejects DA−EDA, the terminally tagged DAAD.
The incorporation mechanism for DAADs appears to be
simpler. We, and others, have previously shown that DAADs
could complement growth in E. coli, B. subtilis, Chlamydia
trachomatis, Mycobacterium smegmatis, and even chloroplasts of
the moss, Physcomitrella patens, when the cytoplasmic DA−DA
pools were depleted by DCS and/or by the generation of
auxotrophic Ddl mutants.16,64,66 Our data here are in
agreement with this finding: DAADs perform similarly to the
endogenous substrate (DA−DA) for dipeptide incorporation
in vitro.
Collectively, our results imply that (F)DAAs report on the
activities of periplasmic D,D-TPases and L,D-TPases, which
explains why (F)DAAs label diverse bacteria so effectively. In
addition, (F)DAAs do not report on any enzyme activity until
the periplasmic biosynthesis of nascent PG is complete (Figure
1a). DAADs, along with a recently reported metabolic
glycolabeling strategy, are complementary to FDAAs in that
they report on the biosynthesis of nascent PG.16,49,67
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Finally, we note that many clinically relevant antibiotics are
DAAs (e.g., DCS, the β-lactams). Our data reveal that DCS, an
important antituberculosis antibiotic, has a previously unrecog-
nized mode of action in addition to its main inhibitory effect
on cytoplasmic stages of PG synthesis. Similar to other DAAs,
we show that DCS can target diverse TPases in evolutionarily
diverse bacteria, including E. coli. Like DCS, many β-lactams
widely used and long-standing anti-D,D-TPase drugshave
terminal DAA moieties that confer them improved anti-
bacterial activities relative to their L-amino acid counter-
parts.40,49 For example, D-ampicillin (or ampicillin) is up to 5-
fold more potent than L-ampicillin, and a synergy between free
DAAs and β-lactams has been shown.5,7,68 It is tantalizing to
think that this synergy points to a DAA-dependent D,D-TPase
“activation” leading to an enhanced sensitivity toward natural
electrophilic β-lactams. If true, and given that (F)DAAs can
selectively target bacteria in live animals,33 this may provide a
promising new avenue for DAA-based antibacterial discovery.
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(50) Tocheva, E. I., Loṕez-Garrido, J., Hughes, H. V., Fredlund, J.,
Kuru, E., VanNieuwenhze, M. S., Brun, Y. V., Pogliano, K., and
Jensen, G. J. (2013) Peptidoglycan transformations during Bacillus
subtilis sporulation. Mol. Microbiol. 88, 673−686.
(51) Tsui, H.-C. T., Boersma, M. J., Vella, S. A., Kocaoglu, O., Kuru,
E., Peceny, J. K., Carlson, E. E., VanNieuwenhze, M. S., Brun, Y. V.,
Shaw, S. L., and Winkler, M. E. (2014) Pbp2x localizes separately
from Pbp2b and other peptidoglycan synthesis proteins during later
stages of cell division of Streptococcus pneumonia D39. Mol. Microbiol.
94, 21−40.
(52) Yang, X., Lyu, Z., Miguel, A., McQuillen, R., Huang, K. C., and
Xiao, J. (2017) GTPase activity-coupled treadmilling of the bacterial
tubulin FtsZ organizes septal cell wall synthesis. Science 355, 744−747.
(53) Pereira, A. R., Hsin, J., Krol, E., Tavares, A. C., Flores, P.,
Hoiczyk, E., Ng, N., Dajkovic, A., Brun, Y. V., VanNieuwenhze, M. S.,
Roemer, T., Carballido-Lopez, R., Scheffers, D.-J., Huang, K. C., and
Pinho, M. G. (2016) FtsZ-dependent elongation of a coccoid
bacterium. mBio 7, No. e00908−16.
(54) Atrih, A., Bacher, G., Allmaier, G., Williamson, M. P., and
Foster, S. J. (1999) Analysis of peptidoglycan structure from
vegetative cells of Bacillus subtilis 168 and role of PBP 5 in
peptidoglycan maturation. Microbiology 181, 3956−3966.
(55) Morales Angeles, D., Liu, Y., Hartman, A. M., Borisova, M., de
Sousa Borges, A., de Kok, N., Beilharz, K., Veening, J. W., Mayer, C.,
Hirsch, A. K., and Scheffers, D. J. (2017) Pentapeptide-rich
peptidoglycan at the Bacillus subtilis cell-division site. Mol. Microbiol.
104, 319−333.
(56) Cava, F., de Pedro, M. A., Lam, H., Davis, B. M., and Waldor,
M. K. (2011) Distinct pathways for modification of the bacterial cell
wall by non-canonical D-amino acids. EMBO J. 30, 3442−3453.
(57) Batson, S., de Chiara, C., Majce, V., Lloyd, A. J., Gobec, S., Rea,
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